Israel: Sight Diagnostics raises US$71m Series D funding

Tel Aviv-based diagnostics company Sight Diagnostics has raised US$71m in Series D funding to support the expansion of Sight’s commercial operations globally and to advance its R&D into the detection of additional diseases as well as biomarkers indicating Covid-19 severity. The round was led by Koch Disruptive Technologies, Longliv Ventures and OurCrowd. To date the…

You must be a HMI Subscriber to view this content.

Subscribe Now »